🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06783543
Active, not recruiting Not applicable

Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema

NCT06783543 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Not applicable
Started
2024-11-13
Last updated
2025-01-20

Condition(s) studied

Lymphedema Arm

Investigational drug(s) / intervention(s)

Comprehensive detumescence treatment with education videoComprehensive detumescence treatment

Comprehensive detumescence treatment with education video: Comprehensive detumescence treatment, including skin care, manual lymphatic drainage, low elastic bandaging and functional exercise four steps

Comprehensive detumescence treatment: Three to five times a week, one hour each time

Study summary

The goal of this clinical trials is to explore the effectiveness of home-based iymphedema treatment and the differences between the home-based and outpatient treatment. The main question is to verify that home-based treatment is as effective as outpatient treatment. We set two groups in this study, comparing the volume of affected upper limb to see if home-based iymphedema treatment is valuable method.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Lymphedema appeared in the upper limb after breast cancer-related treatment, and compared with the healthy side, the edema dimension was more than 2cm. 2. Age 18-75 years old; 3. Edema stage Ⅰ to Ⅱ; Exclusion Criteria: 1. People with severe cognitive impairment; 2. Bilateral lymphedema; 3. Patients undergoing radiotherapy; 4. Patients with uncontrolled tumors; 5. Congestive heart failure and other comprehensive detumescence treatment contraindicated patients.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou Zhejiang

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06783543 on ClinicalTrials.gov ↗ ← All trials in China